Metraipolis › archive › dc_6e90caa96ec7

Significance and challenges of immunopharmacogenomics — Europe PMC PMID:41438736

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41438736
DOI
10.3389/fimmu.2025.1711887
License (as archived)
solo-consultazione
Archived
2026-11-07T19:57:13.787Z
SHA-256 of the archived text
c69e4947003f2c0551a0796be334a07ba04a3a69cdea53c219a85e7ab8ce35ba
Stable URL of this page
https://metraipolis.com/documento/dc_6e90caa96ec7

How to cite

Significance and challenges of immunopharmacogenomics — Europe PMC PMID:41438736 — Europe PMC (en), https://europepmc.org/article/MED/41438736 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_6e90caa96ec7 (Metraipolis archive dc_6e90caa96ec7, sha256 c69e4947003f2c0551a0796be334a07ba04a3a69cdea53c219a85e7ab8ce35ba)
BibTeX
@misc{dc6e90caa96ec7,
  title = {Significance and challenges of immunopharmacogenomics — Europe PMC PMID:41438736},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41438736},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_6e90caa96ec7; sha256 c69e4947003f2c0551a0796be334a07ba04a3a69cdea53c219a85e7ab8ce35ba},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41438736. Agents can read the archived copy with the MCP tool read_document.